RITONAVIR 100 MG

N/A

Manufactured by Cipla USA Inc.

25,519 FDA adverse event reports analyzed

Last updated: 2026-04-14

About RITONAVIR 100 MG

RITONAVIR 100 MG is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Cipla USA Inc.. The most commonly reported adverse reactions for RITONAVIR 100 MG include DRUG INTERACTION, FOETAL EXPOSURE DURING PREGNANCY, MATERNAL EXPOSURE DURING PREGNANCY, VIROLOGIC FAILURE, EXPOSURE DURING PREGNANCY. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for RITONAVIR 100 MG.

Top Adverse Reactions

DRUG INTERACTION2,031 reports
FOETAL EXPOSURE DURING PREGNANCY1,290 reports
MATERNAL EXPOSURE DURING PREGNANCY692 reports
VIROLOGIC FAILURE683 reports
EXPOSURE DURING PREGNANCY633 reports
DRUG RESISTANCE549 reports
OFF LABEL USE544 reports
NAUSEA514 reports
DIARRHOEA512 reports
ACUTE KIDNEY INJURY468 reports
PREMATURE BABY454 reports
TOXICITY TO VARIOUS AGENTS442 reports
ABORTION SPONTANEOUS407 reports
VOMITING405 reports
ANAEMIA399 reports
PYREXIA386 reports
DRUG INEFFECTIVE379 reports
CUSHING^S SYNDROME373 reports
FATIGUE355 reports
DEATH350 reports
ANXIETY345 reports
TREATMENT FAILURE322 reports
PREMATURE DELIVERY294 reports
TREATMENT NONCOMPLIANCE293 reports
DEPRESSION285 reports
HEADACHE282 reports
RASH271 reports
LIPODYSTROPHY ACQUIRED263 reports
RENAL IMPAIRMENT259 reports
ALANINE AMINOTRANSFERASE INCREASED253 reports
PATHOGEN RESISTANCE249 reports
VIRAL MUTATION IDENTIFIED230 reports
RENAL FAILURE221 reports
ASTHENIA214 reports
OSTEOPOROSIS211 reports
ASPARTATE AMINOTRANSFERASE INCREASED207 reports
DYSPNOEA198 reports
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME197 reports
SUICIDAL IDEATION197 reports
PNEUMONIA196 reports
ABDOMINAL PAIN195 reports
BLOOD BILIRUBIN INCREASED194 reports
PAIN194 reports
PSYCHOTIC DISORDER193 reports
LOW BIRTH WEIGHT BABY191 reports
MALAISE190 reports
CD4 LYMPHOCYTES DECREASED186 reports
WEIGHT DECREASED186 reports
NEPHROLITHIASIS184 reports
PRODUCT USE IN UNAPPROVED INDICATION181 reports
DIZZINESS177 reports
MYALGIA176 reports
HYPERTENSION172 reports
BLOOD CREATININE INCREASED168 reports
JAUNDICE168 reports
HYPERBILIRUBINAEMIA165 reports
CONDITION AGGRAVATED164 reports
DRUG EXPOSURE DURING PREGNANCY162 reports
WEIGHT INCREASED153 reports
PARANOIA152 reports
LIVE BIRTH151 reports
PSYCHIATRIC DECOMPENSATION151 reports
RENAL FAILURE ACUTE151 reports
OSTEONECROSIS150 reports
DRUG LEVEL INCREASED148 reports
NEUTROPENIA147 reports
THROMBOCYTOPENIA146 reports
TEARFULNESS142 reports
NO ADVERSE EVENT140 reports
DEPRESSION SUICIDAL138 reports
PANCYTOPENIA138 reports
BLOOD HIV RNA INCREASED137 reports
IMMUNE RECONSTITUTION SYNDROME137 reports
MYOCARDIAL INFARCTION136 reports
PRURITUS136 reports
INSOMNIA135 reports
DEPRESSIVE SYMPTOM131 reports
VIRAL LOAD INCREASED130 reports
COVID 19129 reports
PSYCHOMOTOR SKILLS IMPAIRED129 reports
CONFUSIONAL STATE126 reports
DECREASED APPETITE125 reports
EYELID PTOSIS124 reports
LACTIC ACIDOSIS124 reports
CAESAREAN SECTION121 reports
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED121 reports
ARTHRALGIA118 reports
MITOCHONDRIAL TOXICITY118 reports
NEPHROPATHY TOXIC118 reports
CHRONIC KIDNEY DISEASE117 reports
ABORTION INDUCED113 reports
ADRENAL INSUFFICIENCY113 reports
DEHYDRATION112 reports
DIPLOPIA112 reports
RHABDOMYOLYSIS111 reports
HYPOTENSION110 reports
EMOTIONAL DISTRESS108 reports
HEPATOTOXICITY108 reports
DIABETES MELLITUS107 reports
PANCREATITIS107 reports

Report Outcomes

Out of 14,764 classified reports for RITONAVIR 100 MG:

Serious 92.1%Non-Serious 7.9%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male6,702 (60.6%)
Female4,226 (38.2%)
Unknown138 (1.2%)

Reports by Age

Age 52342 reports
Age 43295 reports
Age 54276 reports
Age 44262 reports
Age 50251 reports
Age 40241 reports
Age 51233 reports
Age 47224 reports
Age 53224 reports
Age 42218 reports
Age 46208 reports
Age 35203 reports
Age 41203 reports
Age 58199 reports
Age 45193 reports
Age 39191 reports
Age 55185 reports
Age 57185 reports
Age 49180 reports
Age 56175 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with RITONAVIR 100 MG?

This profile reflects 25,519 FDA FAERS reports that mention RITONAVIR 100 MG. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for RITONAVIR 100 MG?

Frequently reported terms in FAERS include DRUG INTERACTION, FOETAL EXPOSURE DURING PREGNANCY, MATERNAL EXPOSURE DURING PREGNANCY, VIROLOGIC FAILURE, EXPOSURE DURING PREGNANCY, DRUG RESISTANCE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures RITONAVIR 100 MG?

Labeling and FAERS entries often list Cipla USA Inc. in connection with RITONAVIR 100 MG. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.